Vigilancia centinela de la meningitis bacteriana pediátrica en un hospital pediátrico de IV nivel en Colombia, 2016-2022

dc.contributor.advisorPorras Ramírez, Alexandra
dc.contributor.authorBautista Chaves, Adriana Marcela
dc.date.accessioned2024-08-29T19:44:48Z
dc.date.available2024-08-29T19:44:48Z
dc.date.issued2024-05
dc.description.abstractObjetivo: Describir la etiología, epidemiología y presentación clínica de los pacientes menores de 5 años con MB en el HOMI de 2016 a 2022. Materiales y métodos: Estudio descriptivo de niños menores de 5 años con sospecha de MB. Los casos probables fueron aquellos que tuvieron un resultado de LCR compatible con MB. Los casos confirmados tuvieron un cultivo de LCR o hemocultivo positivo para un patógeno o una prueba molecular positiva para una bacteria en el LCR. Se analizaron variables demográficas, la incidencia de MB por año y la asociación de factores de riesgo con mortalidad o secuelas en pacientes vivos. Resultados: Se estudiaron 449 casos sospechosos de MB; 24.5% (n = 110/449) fueron casos probables y 53.6% (n = 59/110) fueron casos confirmados. El 32.7% de los casos probables y el 37.3% de los casos confirmados fueron menores de 2 años. Los signos y síntomas más frecuentes en los casos confirmados fueron fiebre (84,7%), alteración de la conciencia (40,7%), convulsiones (37,3%) y letargo (32,2%). La tasa de mortalidad fue de 3,3% (n = 2/59); la estancia hospitalaria promedio fue de 34,5 días. Se identificó Spn en 22% y 40% fueron serotipo 15C, Hi en 18,6% y 66,6% tuvieron serotipo b, y Nm en 10,1% y 75% fueron serogrupo C. Otros agentes se observaron en 49,1% de los pacientes. Conclusión: La vigilancia centinela permite medir el impacto de las intervenciones de salud pública y evaluar el impacto de las vacunas ya utilizadas.
dc.description.abstractenglishObjective: To describe the etiology, epidemiology, and clinical presentations of patients under 5 years of age with BM at HOMI from 2016 to 2022. Materials and methods: Descriptive study of children under 5 years of age with suspected BM. Probable cases were those that had a CSF result consistent with BM. Confirmed cases had a positive CSF culture or blood culture for a pathogen or a positive molecular test for a bacterium in the CSF. Demographic variables, the incidence of BM per year and the association of risk factors with mortality or sequelae in living patients were analyzed. Results: 449 suspected cases of BM were studied; 24.5% (n = 110/449) were probable cases, and 53.6% (n = 59/110) were confirmed cases. 32.7% of the probable cases and 37.3% of confirmed cases were under 2 years of age. The most frequent signs and symptoms in the cases confirmed were fever (84.7%), altered consciousness (40.7%), seizures (37.3%) and lethargy (32.2%). The mortality rate was 3.3% (n = 2/59); the average hospital stays were 34.5 days. Spn was identified in 22% and 40% were serotype 15C, Hi in 18.6% and 66.6% had serotype b, and Nm in 10.1% and 75% of were serogroup C. Other agents were observed in 49.1% patients. Conclusion: Sentinel surveillance makes it possible to measure the impact of public health interventions and evaluate the impact of vaccines already used.
dc.description.degreelevelMaestríaspa
dc.description.degreenameMagíster en Epidemiologíaspa
dc.description.sponsorshipHospital Pediatrico la Misericordia
dc.description.sponsorshipOrganización Panamericana de la Salud
dc.description.sponsorshipSecretaria de Salud de Bogotá
dc.description.sponsorshipInstituto Nacional de Salud
dc.format.mimetypeapplication/pdf
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/12915
dc.language.isoen
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.grantorUniversidad El Bosquespa
dc.publisher.programMaestría en Epidemiologíaspa
dc.relation.referencesCamacho-Moreno G, Duarte C, García D, Calderón V, Maldonado LY, Castellar L, Moreno J, Palacios J, Gallego Á, Castillo O, Sanabria O, Talavera I, Montoya R. Sentinel surveillance for bacterial pneumonia and meningitis in children under the age of 5 in a tertiary pediatric hospital in Colombia - 2016. Biomedica. 2021 Oct 15;41(Sp. 2):62-75. doi: 10.7705/biomedica.5658. PMID: 34669279; PMCID: PMC8614369.
dc.relation.referencesCarvalho Mda G, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol 2007; 45:2460–6.
dc.relation.referencesChang CJ, Chang WN, Huang LT, Huang SC, Chang YC, Hung PL, Lu CH, Chang CS, Cheng BC, Lee PY, Wang KW, Chang HW. Bacterial meningitis in infants: the epidemiology, clinical features, and prognostic factors. Brain Dev. 2004 Apr;26(3):168-75. doi: 10.1016/S0387-7604(03)00122-0. PMID: 15030905.
dc.relation.referencesCoronell-Rodriguez W, Caceres DC, Cintra O, Guzman-Holst A. Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis. Infect Dis Ther. 2023 Dec;12(12):2709-2724. doi: 10.1007/s40121-023-00886-y. Epub 2023 Nov 15. PMID: 37966702; PMCID: PMC10746648
dc.relation.referencesDefeating meningitis by 2030: baseline situation analysis (Defeating meningitis by 2030: (who.int)), consultado el 16 de enero de 2024.
dc.relation.referencesEdmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010 May;10(5):317-28. doi: 10.1016/S1473-3099(10)70048-7. PMID: 20417414
dc.relation.referencesEfron A, Nápoli D, Neyro S, Juárez MDV, Moscoloni M, Eluchans NS, Regueira M, Lavayén S; Argentinean H. influenzae Working Group; Faccone D, Santos M. Laboratory surveillance of invasive Haemophilus influenzae disease in Argentina, 2011-2019. Rev Argent Microbiol. 2023 Apr-Jun;55(2):133-142. doi: 10.1016/j.ram.2022.08.002. Epub 2022 Oct 11. PMID: 36229277
dc.relation.referencesFarfán-Albarracín JD, Camacho-Moreno G, Leal AL, Patiño J, Coronell W, Gutiérrez IF, Beltrán S, Álvarez-Olmos MI, Mariño C, Barrero R, Rojas JP, Espinosa F, Arango-Ferreira C, Suarez MA, Trujillo M, López-Medina E, López P, Pinzón H, Ramos N, Moreno VM, Montañez A. Changes in the incidence of acute bacterial meningitis caused by Streptococcus pneumoniae and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10. Front Pediatr. 2022 Sep 23;10:1006887. doi: 10.3389/fped.2022.1006887. PMID: 36210950; PMCID: PMC9545348
dc.relation.referencesFarfán-Albarracín JD, Camacho-Moreno G, Leal AL, Patiño J, Coronell W, Gutiérrez IF, Beltrán S, Álvarez-Olmos MI, Mariño C, Barrero R, Rojas JP, Espinosa F, Arango-Ferreira C, Suarez MA, Trujillo M, López-Medina E, López P, Pinzón H, Ramos N, Moreno VM, Montañez A. Changes in the incidence of acute bacterial meningitis caused by Streptococcus pneumoniae and the implications of serotype replacement in children in Colombia after mass vaccination with PCV10. Front Pediatr. 2022 Sep 23;10:1006887. doi: 10.3389/fped.2022.1006887. PMID: 36210950; PMCID: PMC9545348
dc.relation.referencesGBD 2019 Meningitis Antimicrobial Resistance Collaborators. Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2023 Aug;22(8):685-711. doi: 10.1016/S1474-4422(23)00195-3. PMID: 37479374; PMCID: PMC10356620
dc.relation.referencesHong E, Terrade A, Denizon M, Aouiti-Trabelsi M, Falguières M, Taha MK, Deghmane AE. Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules. BMC Infect Dis. 2021 Jul 30;21(1):715. doi: 10.1186/s12879-021-06440-w. PMID: 34330228; PMCID: PMC8325224
dc.relation.referencesJayaraman Y, Veeraraghavan B, Girish Kumar CP, Sukumar B, Rajkumar P, Kangusamy B, Verghese VP, Varghese R, Jayaraman R, Kapoor AN, Gupta N, Kanagasabai K, David JK, Rajaraman J, Sockalingam G, Khera A, Haldar P, Aggarwal MK, Pillai RK, Manchanda V, Theodore RBJ, Rajahamsan J, Mohan G, Jayalekshmi V, Nedunchelian K, Devasena N, Sridharan S, Selvi R, Ravinder T, Narayana Babu R, Mathevan G, Sugumari C, Sugandhi Rao P, Kini PG, Dwibedi B, Kanga A, Grover N, Narayanan H, Mehendale SM. Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India. Vaccine. 2021 Jun 23;39(28):3737-3744. doi: 10.1016/j.vaccine.2021.05.041. Epub 2021 May 29. PMID: 34074545
dc.relation.referencesKourna Hama M, Khan D, Laouali B, Okoi C, Yam A, Haladou M, Worwui A, Ndow PS, Nse Obama R, Mwenda JM, Biey J, Ntsama B, Kwambana-Adams BA, Antonio M. Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction. Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S133-S139. doi: 10.1093/cid/ciz598. PMID: 31505636; PMCID: PMC6761310
dc.relation.referencesLa Rotta Cepeda, Jorge Enrique. Cost-effectiveness analysis of alternate strategies for children immunization against meningococcal disease with quadrivalent conjugate vaccines in Colombia. 2020. Available in: Cost-effectiveness analysis of alternate strategies for children immunization against meningococcal disease with quadrivalent conjugate vaccines in Colombia (513.9Kb)
dc.relation.referencesMoreno J, Alarcon Z, Parra E, Duarte C, Sanabria O, Prada D, Gabastou JM. Molecular characterization of Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease in Colombia from 2013 to 2016. PLoS One. 2020 Jul 14;15(7):e0234475. doi: 10.1371/journal.pone.0234475. PMID: 32663215; PMCID: PMC7360035
dc.relation.referencesNakamura T, Cohen AL, Schwartz S, Mwenda JM, Weldegebriel G, Biey JNM, et al. The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S161-S173. doi: 10.1093/infdis/jiab217. PMID: 34469555; PMCID: PMC8409679.
dc.relation.referencesNakamura T, Cohen AL, Schwartz S, Mwenda JM, Weldegebriel G, Biey JNM, Katsande R, Ghoniem A, Fahmy K, Rahman HA, Videbaek D, Daniels D, Singh S, Wasley A, Rey-Benito G, de Oliveira L, Ortiz C, Tondo E, Liyanage JBL, Sharifuzzaman M, Grabovac V, Batmunkh N, Logronio J, Heffelfinger J, Fox K, De Gouveia L, von Gottberg A, Du Plessis M, Kwambana-Adams B, Antonio M, El Gohary S, Azmy A, Gamal A, Voropaeva E, Egorova E, Urban Y, Duarte C, Veeraraghavan B, Saha S, Howden B, Sait M, Jung S, Bae S, Litt D, Seaton S, Slack M, Antoni S, Ouattara M, Van Beneden C, Serhan F. The Global Landscape of Pediatric Bacterial Meningitis Data Reported to the World Health Organization-Coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S161-S173. doi: 10.1093/infdis/jiab217. PMID: 34469555; PMCID: PMC8409679
dc.relation.referencesNational Institute of Health. Laboratory surveillance of Streptococcus pneumoniae in Colombia, 2016-202. Available at https://www.ins.gov.co/BibliotecaDigital/vigilancia-por-laboratorio-de-streptococcus-pneumoniae-en-colombia-2016-2021.pdf
dc.relation.referencesOordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: A systematic review and meta-analysis. PLoS One. 2018 Jun 11;13(6):e0198772. doi: 10.1371/journal.pone.0198772. PMID: 29889859; PMCID: PMC5995389
dc.relation.referencesOuattara M, Whaley MJ, Jenkins LT, et al. Triplex real-time PCR assay for the detection of Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae directly from clinical specimens without extraction of DNA. Diagn Microbiol Infect Dis 2019; 93:188–90.
dc.relation.referencesPeltola, H., Roine, I., Kallio, M. et al. Outcome of childhood bacterial meningitis on three continents. Sci Rep 11, 21593 (2021). https://doi.org/10.1038/s41598-021-01085-w
dc.relation.referencesPerformance Standards for Antimicrobial Susceptibility Testing: Twenty-sixth Informational Supplement Clinical Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: 33rd Edition. 2023.
dc.relation.referencesPimenta FC, Roundtree A, Soysal A, et al. Sequential triplex real-time PCR assay for detecting 21 pneumococcal capsular serotypes that account for a high global disease burden. J Clin Microbiol 2013; 51:647–52.Wang X, Theodore MJ, Mair R, et al. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens. J Clin Microbiol 2012; 50:702–8.
dc.relation.referencesPitre-Daza, A. D., Guerrero-Gómez, M. G., & Gelvez-Ávila, R. E. (2023). Meningitis Bacteriana y sus Complicaciones a Corto Plazo en Niños de 0 a 5 Años en el Hospital Universitario Erasmo Meoz en el Lapso 2019-2021
dc.relation.referencesRenner LA, Usuf E, Mohammed NI, Ansong D, Dankwah T, Kusah JT, Owusu SK, Awunyo M, Arhin B, Addo Y, Asamoah J, Biey JN, Ndow PS, Worwui A, Senghore M, Ntsama B, Mwenda JM, Diamenu SK, Adams BK, Antonio M. Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana. Clin Infect Dis. 2019 Sep 5;69(Suppl 2):S89-S96. doi: 10.1093/cid/ciz464. PMID: 31505622; PMCID: PMC6736167
dc.relation.referencesRodríguez, Mabel Karina, Agudelo, Clara Inés, & Duarte, Carolina. (2015). Aislamientos invasivos de Haemophilus influenzae en menores de 5 años: distribución de los serotipos y de la sensibilidad antimicrobiana, SIREVA II, Colombia 2002-2013. Infectio, 19(2), 67-74. https://doi.org/10.1016/j.infect.2014.12.005
dc.relation.referencesRojas JP, Leal AL, Patiño J, Montañez A, Camacho G, Beltrán S, et al. Caracterización de pacientes fallecidos por enfermedad neumocóccica invasiva en la poblacion infantil de Bogotá, Colombia. Rev Chil Pediatría. enero de 2016;87(1):48-52.
dc.relation.referencesSlack M, Esposito S, Haas H, Mihalyi A, Nissen M, Mukherjee P, Harrington L. Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication. Expert Rev Vaccines. 2020 Oct;19(10):903-917. doi: 10.1080/14760584.2020.1825948. Epub 2020 Oct 10. PMID: 32962476
dc.relation.referencesSlack MPE, Cripps AW, Grimwood K, Mackenzie GA, Ulanova M. Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use. Clin Microbiol Rev. 2021 Jun 16;34(3):e0002821. doi: 10.1128/CMR.00028-21. Epub 2021 Jun 2. PMID: 34076491; PMCID: PMC8262803
dc.relation.referencesSnoek L, Gonçalves BP, Horváth-Puhó E, van Kassel MN, Procter SR, Søgaard KK, Chandna J, van der Ende A, van de Beek D, Brouwer MC, Sørensen HT, Lawn JE, Bijlsma MW. Short-term and long-term risk of mortality and neurodevelopmental impairments after bacterial meningitis during infancy in children in Denmark and the Netherlands: a nationwide matched cohort study. Lancet Child Adolesc Health. 2022 Sep;6(9):633-642. doi: 10.1016/S2352-4642(22)00155-9. Epub 2022 Jul 5. PMID: 35798010; PMCID: PMC9365703.
dc.relation.referencesTeixeira DC, Diniz LMO, Guimarães NS, Moreira HMAS, Teixeira CC, Romanelli RMC. Risk factors associated with the outcomes of pediatric bacterial meningitis: a systematic review. J Pediatr (Rio J). 2020 Mar-Apr;96(2):159-167. doi: 10.1016/j.jped.2019.07.003. Epub 2019 Aug 19. PMID: 31437421; PMCID: PMC9432045
dc.relation.referencesTuyama, M., Corrêa-Antônio, J., Schlackman, J., Marsh, J. W., Rebelo, M. C., Cerqueira, E. O., ... & Barroso, D. E. (2017). Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil. Memórias do Instituto Oswaldo Cruz, 112, 196-202
dc.relation.referencesVan de Beek D, Brouwer MC, Koedel U, Wall EC. Community-acquired bacterial meningitis. Lancet. 2021 Sep 25;398(10306):1171-1183. doi: 10.1016/S0140-6736(21)00883-7. Epub 2021 Jul 22. PMID: 34303412.
dc.relation.referencesVuong J, Collard JM, Whaley MJ, et al. Development of real-time PCR methods for the detection of bacterial meningitis pathogens without DNA extraction. PLoS One 2016; 11:e0147765.
dc.relation.referencesWorld Health Organization and Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, andHaemophilus influenzae: WHO manual. 2nd ed. https://apps.who.int/iris/handle/10665/70765. Accessed 15 January 2023.
dc.relation.referencesWu J, Song X, Hu Y, Chen J, Jiang L. High-risk factors associated with refractory childhood bacterial meningitis in Southwest China. BMC Pediatr. 2023 May 5;23(1):220. doi: 10.1186/s12887-023-04007-z. PMID: 37147568; PMCID: PMC10163699
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.localAcceso abiertospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectMeningitis
dc.subjectStreptococcus pneumoniae
dc.subjectHaemophilus influenzae, Neisseria meningitidis, centinela.
dc.subjectNeisseria meningitidis
dc.subjectCentinela
dc.subject.keywordsMeningitis
dc.subject.keywordsStreptococcus pneumoniae
dc.subject.keywordsHaemophilus influenzae
dc.subject.keywordsNeisseria meningitidis
dc.subject.keywordsSentinel
dc.subject.nlmWA 105
dc.titleVigilancia centinela de la meningitis bacteriana pediátrica en un hospital pediátrico de IV nivel en Colombia, 2016-2022
dc.title.translatedSentinel surveillance on pediatric bacterial meningitis in a IV level pediatric hospital in Colombia, 2016-2022
dc.type.coarhttps://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttps://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesis/Trabajo de grado - Monografía - Maestríaspa

Archivos

Bloque original
Mostrando 1 - 2 de 2
No hay miniatura disponible
Nombre:
Trabajo de grado.pdf
Tamaño:
691.98 KB
Formato:
Adobe Portable Document Format
No hay miniatura disponible
Nombre:
Anexo 2 Tablas y figuras.pdf
Tamaño:
878.78 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 3 de 3
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.95 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
No hay miniatura disponible
Nombre:
Carta de autorizacion.pdf
Tamaño:
2.49 MB
Formato:
Adobe Portable Document Format
Descripción:
No hay miniatura disponible
Nombre:
Anexo 1 Probatus.pdf
Tamaño:
186.03 KB
Formato:
Adobe Portable Document Format
Descripción: